[Optimization using the pharmacokinetics of the therapeutic index of CDDP-5 FU treatment over 5 continuous days].
Milano
G
G
Centre Antoine-Lacassagne, Nice, France.
Santini
J
J
Thyss
A
A
Reneè
N
N
Veins
P
P
Chauvel
P
P
Schneider
M
M
Demard
F
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012189:Retrospective Studies
D002945:Cisplatin; D005472:Fluorouracil
Optimisation par la pharmacocinétique de l'index thérapeutique du traitement cddp-5 fu cinq jours continu.